248 related articles for article (PubMed ID: 16234182)
1. Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital.
Wick MC; Ernestam S; Lindblad S; Bratt J; Klareskog L; van Vollenhoven RF
Scand J Rheumatol; 2005; 34(5):353-8. PubMed ID: 16234182
[TBL] [Abstract][Full Text] [Related]
2. Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.
Schabert VF; Watson C; Joseph GJ; Iversen P; Burudpakdee C; Harrison DJ
J Manag Care Pharm; 2013 Oct; 19(8):621-30. PubMed ID: 24074008
[TBL] [Abstract][Full Text] [Related]
3. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.
Stagakis I; Bertsias G; Karvounaris S; Kavousanaki M; Virla D; Raptopoulou A; Kardassis D; Boumpas DT; Sidiropoulos PI
Arthritis Res Ther; 2012 Jun; 14(3):R141. PubMed ID: 22691241
[TBL] [Abstract][Full Text] [Related]
5. CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis.
Krintel SB; Essioux L; Wool A; Johansen JS; Schreiber E; Zekharya T; Akiva P; Ostergaard M; Hetland ML
PLoS One; 2012; 7(6):e38539. PubMed ID: 22685579
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry.
Vallejo-Yagüe E; Burkard T; Finckh A; Burden AM;
BMJ Open; 2024 Feb; 14(2):e074864. PubMed ID: 38331859
[TBL] [Abstract][Full Text] [Related]
7. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review.
Rubbert-Roth A; Finckh A
Arthritis Res Ther; 2009; 11 Suppl 1(Suppl 1):S1. PubMed ID: 19368701
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of switching between biologics in psoriatic arthritis- results of a large regional survey.
Jani M; Macphie E; Rao C; Moore S; Mirjafari H; McLoughlin Y; Chinoy H; Shah P
Clin Med (Lond); 2014 Feb; 14(1):95-6. PubMed ID: 24532765
[No Abstract] [Full Text] [Related]
9. The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project.
Leeb BF; Böttcher E; Brezinschek HP; Czerwenka C; Herold M; Hitzelhammer H; Mayrhofer F; Puchner R; Rainer F; Rintelen B; Schirmer M; Stuby U; Bröll H
Clin Rheumatol; 2010 Feb; 29(2):167-74. PubMed ID: 19904485
[TBL] [Abstract][Full Text] [Related]
10. Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis.
Freeze R; Yang KW; Haystead T; Hughes P; Scarneo S
Pharmacol Res Perspect; 2023 Aug; 11(4):e01124. PubMed ID: 37564034
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor α-associated diseases from a molecular view.
Hu S; Liang S; Guo H; Zhang D; Li H; Wang X; Yang W; Qian W; Hou S; Wang H; Guo Y; Lou Z
J Biol Chem; 2013 Sep; 288(38):27059-27067. PubMed ID: 23943614
[TBL] [Abstract][Full Text] [Related]
12. DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis.
van Riel PL; Fransen J
Arthritis Res Ther; 2005; 7(5):189-90. PubMed ID: 16207346
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical characterization and functionality comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria®(golimumab).
Kinzer JL; Halseth TA; Kang J; Kim SY; Kumaran P; Ford M; Saveliev S; Skilton SJ; Schwendeman A
Int J Pharm; 2023 Mar; 635():122646. PubMed ID: 36709835
[TBL] [Abstract][Full Text] [Related]
14. Sequentiality of treatment in the rheumatoid arthritis drug programme in the years 2009-2014.
Tłustochowicz M; Śliwczyński AM; Brzozowska M; Teter Z; Marczak M
Arch Med Sci; 2018 Apr; 14(3):569-571. PubMed ID: 29765444
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report.
Vural S; Kuşdoğan M; Kaya HB; İkiz V; Albayrak L
Indian J Otolaryngol Head Neck Surg; 2023 Jun; 75(2):1013-1015. PubMed ID: 37274971
[TBL] [Abstract][Full Text] [Related]
16. Study on Cloning and Expression of TNF-α Variants in E. coli: Production, Purification, and Interaction with Anti-TNF-α Inhibitors.
Akçadağ G; Cansaran-Duman D; Aras ES; Ataoğlu H
Protein Pept Lett; 2024 Jun; ():. PubMed ID: 38847260
[TBL] [Abstract][Full Text] [Related]
17. Anti-TNF Alpha Antibody Humira with pH-dependent Binding Characteristics: A constant-pH Molecular Dynamics, Gaussian Accelerated Molecular Dynamics, and In Vitro Study.
Hong ST; Su YC; Wang YJ; Cheng TL; Wang YT
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672169
[TBL] [Abstract][Full Text] [Related]
18. Three cases of previous smokers with rheumatoid arthritis who did not respond to tumor necrosis factor inhibitors were treated successfully with an anti-interleukin-6 receptor antibody.
Iwata Y
Case Rep Rheumatol; 2015; 2015():806725. PubMed ID: 25648415
[TBL] [Abstract][Full Text] [Related]
19. Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab).
Tebbey PW; Varga A; Naill M; Clewell J; Venema J
MAbs; 2015; 7(5):805-11. PubMed ID: 26230301
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
